Press digest - November 5
AZN•AZN•AZN•AZN•AstraZeneca reportedly made a roughly $10 billion offer to buy Rhythm Pharmaceuticals, a deal that would expand its rare disease portfolio. Other items include Ethan Allen board changes and The Andersons’ $915 million acquisition of Harvestone Low Carbon Partners.
AstraZeneca recently made a roughly $10 billion offer to buy Rhythm Pharmaceuticals, according to people familiar with the matter. The deal would expand AstraZeneca’s portfolio of rare disease treatments.
Investors elected three nominees of activist Douglas Bergeron to Ethan Allen’s board, giving him control of the five-person board, preliminary voting results showed. The Andersons agreed to buy low-carbon ethanol producer Harvestone Low Carbon Partners for $915 million, expanding its renewables platform by more than 40%.
Israel has ordered billions of dollars’ worth of American military hardware beyond what the US has committed to pay for. Hong Kong activist Joshua Wong was sentenced to 10 years in jail on a charge of collusion with foreign entities under the city’s national security law.
